Journal
Molecular Therapy Oncolytics
Publication Date
3-17-2022
Volume
24
First Page
585
Last Page
596
Document Type
Open Access Publication
DOI
10.1016/j.omto.2022.02.009
Rights and Permissions
Cubitt CC, McClain E, Becker-Hapak M, Foltz JA, Wong P, Wagner JA, Neal CC, Marin ND, Marsala L, Foster M, Schappe T, Soon-Shiong P, Lee J, Berrien-Elliott MM, Fehniger TA. A novel fusion protein scaffold 18/12/TxM activates the IL-12, IL-15, and IL-18 receptors to induce human memory-like natural killer cells. Mol Ther Oncolytics. 2022 Feb 15;24:585-596. doi: 10.1016/j.omto.2022.02.009. https://www.cell.com/molecular-therapy-family/oncolytics/fulltext/S2372-7705(22)00026-2 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Cubitt, Celia C; McClain, Ethan; Becker-Hapak, Michelle; Foltz, Jennifer A; Wong, Pamela; Wagner, Julia A; Neal, Carly C; Marin, Nancy D; Marsala, Lynne; Foster, Mark; Schappe, Timothy; Soon-Shiong, Patrick; Lee, John; Berrien-Elliott, Melissa M; and Fehniger, Todd A, "A novel fusion protein scaffold 18/12/TxM activates the IL-12, IL-15, and IL-18 receptors to induce human memory-like natural killer cells." Molecular Therapy Oncolytics. 24, 585 - 596. (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11442
